A Consortium of Harvard University, Boston University, Northwestern University, and University of New Mexico
Announcing a new, one-year NIH-funded opportunity for early-career investigatorsinterested in working in low-resource settings. The Harvard-BU-Northwestern-UNM Fogarty Partnership for Global Health Research Training provides supportive mentorship, research opportunities and a collaborative research environment for early stage investigators to enhance their global health research expertise and their careers. Read more about Fogarty Fellowships Available - Applications Due Feb. 28, 2017
What: Pilot grants will be awarded with funding up to $50k in total costs. The HU CFAR will provide matching funds of $10k for up to 2 applications chosen for funding. The investigator(s) will need to be a Harvard University CFAR affiliated investigator.
The same standard of medical care will be key in globally combatting the rise of drug resistant strains of HIV. Access to testing for signs of viral resistance, tailored ART regimens, and more expensive and less toxic drugs are just some of the treatment advantages in developed nations. In countries such as Kenya, Zambia, Uganda, Nigeria, Tanzania and South Africa, the alarming trend of drug resistance has nothing to do with efforts on the part of an HIV patient to adhere to medication regimens, but on other factors of access and instability. Read more about Dr. Jonathan Li Talks to the Huffington Post about the Increasing Risk of Drug Resistance